The relationship between gut bacteria and colon cancer has become a significant area of research, as scientists seek to understand how changes in the gut microbiome might influence the development of precancerous colon polyps and their progression to cancer. A recent study published in the journal Cell Host & Microbe highlights the role of certain gut bacteria in increasing the chances that colon polyps will become cancerous. This research, led by William DePaolo, associate professor at the University of Washington School of Medicine, sheds light on how specific bacteria, such as non-enterotoxigenic Bacteroides fragilis, are more prominent in patients with colon polyps compared to those without the polyps.
Colorectal cancer is amongst the biggest health concerns, ranking as the third leading cause of cancer in the United States, with its incidence rising among young adults. Nearly all colorectal cancers originate from precancerous polyps, making early discovery and intervention important for reducing cancer rates. The gut microbiome, composed of trillions of microorganisms living in the gastrointestinal tract, plays an imperative role in health and disease.
The Role of Bacteroides fragilis
DePaolo’s research focused on identifying bacteria present in higher levels near colon polyps compared to polyp-free areas. The study involved 40 patients aged 50 to 75, with 60% being women, who underwent routine colonoscopies and biopsies near the polyps. The findings revealed that Bacteroides fragilis, a common gut bacteria, was higher in mucosal biopsies of patients with polyps. Moreover, the study established a correlation between the amount of B. fragilis and the inflammation of small polyps.
Interestingly, the B. fragilis from patients with polyps differed in its ability to induce inflammation compared to B. fragilis from polyp-free individuals. This suggests that even normally healthy bacteria can adapt and contribute to inflammation in environments where metabolic and inflammatory changes occur. This adaptation could potentially push a polyp toward cancer.
Gut Bacteria as Indicators of Colon Cancer Risk
The study also identified distinct microbial signatures that differentiate patients with polyps from those without. These findings suggest that gut bacteria could serve as indicators of colon cancer risk. Only about 5% of colon polyps become cancerous, but they often develop in the same areas of the colon repeatedly, according to the research. This pattern suggests that new screenings could focus on detecting key bacteria, such as specific strains of B. fragilis, before precancerous polyps form. Such screenings could potentially reduce colorectal cancer rates by identifying at-risk individuals early.
Other research supports the idea that certain bacteria can predict colon cancer risk. For example, studies have found that Escherichia, Shigella, and Bacteroides may serve as biomarkers for early detection of colorectal polyps. These bacteria are more readily available in patients with polyps compared to healthy controls, indicating their potential role in polyp development and progression.
Impact of Diet on Gut Bacteria and Colon Cancer
Diet plays a significant role in shaping the gut microbiome and its influence on colon cancer. A study from the University of Toronto found that a low-carbohydrate diet can worsen the DNA-damaging effects of certain gut microbes, leading to colorectal cancer development in mice. Specifically, a unique strain of E. coli that produces the DNA-damaging compound colibactin, when paired with a low-carb diet, drove the growth of polyps in the colon.
Similarly, a low-carb, low-fiber diet has been linked to an increased risk of colorectal cancer, as it may alter the balance of gut bacteria in a way that promotes polyp formation. High consumption of red and processed meats, smoking, and alcohol use are also risk factors for colorectal cancer and can influence the gut microbiome.
Future Directions in Screening and Prevention
The next step in DePaolo’s research involves expanding the study to 200 patients to explore whether fecal samples could be used as a substitute for mucosal biopsies. This approach could simplify screening processes and make them more accessible. If successful, such screenings could identify individuals at risk before polyps develop, offering a critical window for intervention and subsequent treatment.
Moreover, understanding the role of gut bacteria in colon cancer development opens up new avenues for prevention and treatment. Targeting specific bacteria or modifying the gut microbiome through dietary changes or probiotics could become part of a full-scale strategy to reduce colorectal cancer incidence. As research continues, it may lead to more personalized and effective approaches to managing colorectal cancer.
Conclusion
Studies like DePaolo’s highlight the potential for gut bacteria to serve as indicators of colon cancer risk and underscore the importance of considering the microbiome in cancer prevention strategies. As scientists continue to explore how diet, lifestyle, and microbiome interactions influence cancer development, they move closer to developing innovative and effective diagnostic tools and therapeutic interventions. Ultimately, understanding and manipulating the gut microbiome could become a key component in the fight against colorectal cancer.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Read More: